Nothing to do with yesterday's intelligent commentary.
This is a further example of BOD making newsflow to enhance their stock price.
they have yet to prescribe their product to a single patient in the UK.
their product is SOMEONE ELSE's (Linnea's) product and they do not own the IP over it.
They are selling someone else's products for less than they buy for.
It's all CAPITAL MARKET TRICKERY.
Ann: Bod to take part in European medicinal cannabis project, page-3
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable